Search results
1 company and 24 research reports found for "Acta"
Company results
- Acta
Acta develops and produces clean technology products for hydrogen generation, power generation and o...
Sector reports
No sector reports have been found.
Research results
QRxPharma
Actavis deal signed
QuickView | Pharmaceutical & Healthcare | 28/03/2012QRxPharma is moving rapidly towards the commercial phase for its lead product, MoxDuo IR, an immediate release fixed-ratio (3:2) combination of morphi...
Ligand Pharmaceuticals
ENABLE-ing growth
QuickView | Pharmaceutical & Healthcare | 14/11/2011Ligand Pharmaceuticals’ partner GlaxoSmithKline presented Phase III data from two trials that showed that Promacta raised and maintained platele...
Hightex Group
Look to the sky
Outlook | Construction & Building Materials | 22/04/2010The €19m Kiev contract, the largest ever achieved, and the recent Vancouver contract wins have further confirmed Hightex’s repositioning strategy,...
Hightex Group
Towards the skies
Outlook | Construction & Building Materials | 11/11/2009The successful installation and completion of the retractable roof at Wimbledon’s Centre Court and the recent €19m Kiev stadium contract win...
Optim profit
Outlook | Pharmaceutical & Healthcare | 18/05/2009Avacta has evolved through the acquisition of four businesses, including three in early 2009 bringing c £3.6m cash and annualised revenues of ove...
Deal to acquire Curidium
Update | Pharmaceutical & Healthcare | 12/01/2009Avacta is to acquire Curidium via a recommended all-share offer that values the UK personalised medicine firm at just over £6.2m, an approximate ...
Moving towards launch
Review | Pharmaceutical & Healthcare | 08/12/2008Avacta has met its key product development milestones in 2008 and remains on track to launch its first products – including the Optim device ...
Catalysts required
Update | Engineering | 30/09/2008Acta’s earnings remain tied to the R&D budgets of its major partner, as most of its projects are currently in their cash-consuming development p...
Progress towards launch
Update | Pharmaceutical & Healthcare | 06/08/2008Avacta is making good progress in its development of automated bioanalytical instruments, including the important Optim product that is nearing launch...
Management in depth
Update | Engineering | 23/06/2008While it is sad to see the departure of Toby Woolrych, COO from Acta because he has done much drive the commercialisation of this business and investo...
Broader attraction
Outlook | Engineering | 25/03/2008With another set of encouraging results, Acta has built a solid track record of delivering to planned perfomance. During 2007, the company developed i...
Spectroscopic expertise
Outlook | Pharmaceutical & Healthcare | 12/03/2008Avacta is developing a series of automated bioanalytical instruments of broad utility in a number of sectors. These are based on its leading expertise...
Big steps forward
Update | Engineering | 21/01/2008Confirmation that 2007 revenues increased ahead of our forecasts and net losses will be lower than expected is welcome, though the large steps forward...
First development contract
Update | Engineering | 28/11/2007This contract win catapults Acta to the front of the UK quoted fuel cell sector as one of the most commercially advanced suppliers. Its technology has...
Building a customer base
Review | Engineering | 21/09/2007Further new customers, new non disclosure agreements (NDAs), and a series of repeat orders suggest that the commercial outlook is beginning to catch u...
Refinancing endorsement
Trading update | Engineering | 12/07/2007Announcement of an investment in Acta by its marketing partner, Sumitomo, looks to be a strong endorsement of customer progress. Acta has beaten its d...
Accelerating performance
Outlook | Engineering | 21/03/2007Acta has made rapid progress against all its key technical and commercial goals in 2006. The pace of development will accelerate during 2007 with impr...
Foundations complete
Update | Engineering | 22/01/2007Acta’s pre-close statement shows further commercial and technical progress in H2. This confirms management has met development promises, is now ...
Designer catalysts
Update | Engineering | 22/09/2006Significant progress in winning potential new customers and extending the applications of HYPERMEC catalysts shows Acta’s development programme ...
Appealing valuation
Company Comment - Interim results | Financials | 13/09/2006Record profits of £30.3m for the first half of 2006 reflect transactional timing and a validation of IP’s business model. Two IPOs, private...
Meeting technical targets
Review | Engineering | 03/07/2006Acta's AGM statement confirms the company is making steady progress towards commercialisation of its catalyst products. At the same time there is more...
Timetable on track
Quarterly update | Engineering | 23/03/2006As a component supplier to the fuel industry, Acta may have a lower profile than some of the system manufacturers; however its investment story remain...
Encouraging trading
Update | Engineering | 24/01/2006Acta’s trading statement this month shows it is delivering on the route map towards commercialisation that it outlined in the autumn. With a gro...
Fuel cell catalyst
Outlook | Engineering | 08/12/2005Acta is an Italian material science company that listed on the UK AIM market in October. It has patented platinum-free catalyst technology that can en...
